Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2006The Journal of ImmunologyOpen Access

Antiangiogenic and Antitumor Activities of IL-27

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMotomu ShimizuTokyo Metropolitan Institute of Public HealthMSMariko ShimamuraThe University of OsakaTOToshiyuki OwakiTokyo Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shimizu et al. (2006) studied this question.

synapsesocial.com/papers/6a7c979694a67f751aba5ac8https://doi.org/10.4049/jimmunol.176.12.7317
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antitumor and antimetastatic activity of interleukin 12 against murine tumors.1993 · 1,211 citations
  2. 2Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.1998 · 423 citations
  3. 3Interleukin‐18 acts as an angiogenesis and tumor suppressor1999 · 209 citations
  4. 4IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells2004 · 160 citations
  5. 5Expression of IL‐27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals2005 · 124 citations